Affiliation:
1. Department of Translational Immunology and Experimental Intensive Care, Centre of Postgraduate Medical Education, Marymoncka 99/103, 01-813 Warsaw, Poland
Abstract
Due to the global crisis caused by the dramatic rise of drug resistance among Gram-negative bacteria, there is an urgent need for a thorough understanding of the pathogenesis of infections of such an etiology. In light of the limited availability of new antibiotics, therapies aimed at host–pathogen interactions emerge as potential treatment modalities. Thus, understanding the mechanism of pathogen recognition by the host and immune evasion appear to be the key scientific issues. Until recently, lipopolysaccharide (LPS) was recognized as a major pathogen-associated molecular pattern (PAMP) of Gram-negative bacteria. However, recently, ADP-L-glycero-β-D-manno-heptose (ADP-heptose), an intermediate carbohydrate metabolite of the LPS biosynthesis pathway, was discovered to activate the hosts’ innate immunity. Therefore, ADP-heptose is regarded as a novel PAMP of Gram-negative bacteria that is recognized by the cytosolic alpha kinase-1 (ALPK1) protein. The conservative nature of this molecule makes it an intriguing player in host–pathogen interactions, especially in the context of changes in LPS structure or even in its loss by certain resistant pathogens. Here, we present the ADP-heptose metabolism, outline the mechanisms of its recognition and the activation of its immunity, and summarize the role of ADP-heptose in the pathogenesis of infection. Finally, we hypothesize about the routes of the entry of this sugar into cytosol and point to emerging questions that require further research.
Funder
Polish National Science Centre
Subject
Virology,Microbiology (medical),Microbiology
Reference92 articles.
1. (2017, February 27). Available online: https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed.
2. Infectious Diseases Society of America (ScienceDaily, 2008). No ESKAPE! New Drugs against MRSA, Other Superbugs Still Lacking, ScienceDaily.
3. Cui, J., Duizer, C., Bouwman, L.I., van Rooijen, K.S., Voogdt, C.G.P., van Putten, J.P.M., and de Zoete, M.R. (2021). The ALPK1 pathway drives the inflammatory response to Campylobacter jejuni in human intestinal epithelial cells. PLoS Pathog., 17.
4. Alpha-kinase 1 is a cytosolic innate immune receptor for bacterial ADP-heptose;Zhou;Nature,2018
5. ADP-heptose is a newly identified pathogen-associated molecular pattern of Shigella flexneri;Dangeard;EMBO Rep.,2018